scispace - formally typeset
X

Xiaoli Zou

Researcher at Huazhong University of Science and Technology

Publications -  5
Citations -  529

Xiaoli Zou is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Persulfate & Catalysis. The author has an hindex of 3, co-authored 3 publications receiving 350 citations.

Papers
More filters
Journal ArticleDOI

Decomposition of sulfadiazine in a sonochemical Fe0-catalyzed persulfate system: Parameters optimizing and interferences of wastewater matrix

TL;DR: In this paper, an effective decomposition of antibiotic sulfadiazine (SD) in a Fe0-catalyzed sonochemical Fenton like system (Sono-FL) was demonstrated.
Journal ArticleDOI

Synergistic degradation of antibiotic sulfadiazine in a heterogeneous ultrasound-enhanced Fe0/persulfate Fenton-like system

TL;DR: In this paper, a novel ultrasoundenhanced heterogeneous Fe 0 /persulfate (US/Fe 0 /PS) system was developed and investigated for the degradation of an antibiotic sulfadiazine (SD).
Journal ArticleDOI

Synergistic degradation of antibiotic norfloxacin in a novel heterogeneous sonochemical Fe0/tetraphosphate Fenton-like system.

TL;DR: An integrated reaction mechanism in the US/ZVI/TPP system was proposed including solid-liquid interfacial iron corrosion as well as bulk homogenous oxygen activation and Fenton reactions, wherein US would play mechanically and chemically promotional roles.
Journal ArticleDOI

Fabrication of the SnS2/ZnIn2S4 heterojunction for highly efficient visible light photocatalytic H2 evolution

TL;DR: In this article , a series of SnS 2 /ZnIn 2 S 4 ( x -SS/ZIS) photocatalysts with different mass ratios of SNS 2 were prepared by a hydrothermal method.
Journal ArticleDOI

Efficient decontamination of RO concentrate in a sonochemical zero-valent iron/persulfate Fenton-like system: The molecule-size preferred degradation of dissolved organic matters

TL;DR: In this article , an ultrasound/zero valent iron/persulfate (US/ZVI/PS) system has been developed to degrade typical antibiotic sulfadiazine in the presence of co-existing ROC DOMs.